Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Twist Bioscience Corp (NQ: TWST ) 44.18 -0.94 (-2.08%) Streaming Delayed Price Updated: 3:54 PM EDT, Aug 28, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Twist Bioscience Corp < Previous 1 2 3 4 5 6 7 8 Next > Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability January 31, 2022 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics January 25, 2022 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022 January 20, 2022 From Twist Bioscience Corporation Via Business Wire Twist Bioscience’s Comprehensive DNA Synthesis Capabilities Expanded as Industry-Leading Enzymatic Synthesis Process Unveiled at Annual J.P. Morgan Healthcare Conference January 10, 2022 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Creates Custom Whole Exome Target Enrichment Panel for Canine Genomic Research January 06, 2022 From Twist Bioscience Corporation Via Business Wire Revelar Biotherapeutics and Twist Bioscience Announce RBT-0813 Neutralizes SARS-CoV-2 Omicron (B.1.1.529/BA.1) and Delta (B.1.617.2) Variants January 05, 2022 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at the 40th Annual J.P. Morgan Healthcare Conference January 04, 2022 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches 96-Plex Library Prep Kit for Low Pass High Throughput Next-Generation Sequencing December 20, 2021 From Twist Bioscience Corporation Via Business Wire Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets December 16, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Now Shipping Synthetic RNA Positive Controls for Omicron (B.1.1.529/BA.1) SARS-CoV-2 Variant for Development of Accurate Diagnostic Tests December 15, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Circulating Tumor DNA Reference Controls for Development of Liquid Biopsy Assays December 07, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Announces Participation in SRC-SIA Webinar on the Decadal Plan for Semiconductors November 30, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at Upcoming Virtual Conferences November 24, 2021 From Twist Bioscience Via Business Wire Twist Bioscience Reports Fourth Quarter and Full Year Fiscal 2021 Financial Results November 22, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities November 22, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Expands Partnership with Invetx to Include Discovery of Best-in-Class Antibodies to Treat Multiple Diseases in Cats and Dogs November 18, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19 and Other Antibody Therapeutics for Difficult to Treat Diseases November 15, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Present at the Stifel 2021 Virtual Healthcare Conference November 09, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Named in Inc.’s First Annual Best-Led Companies List November 02, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience to Report Fiscal 2021 Fourth Quarter and Full Year Financial Results on Monday, November 22, 2021 November 01, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Launches Exome 2.0 for Genomics Research October 20, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience and the Broad Institute Create Custom Whole Exome Target Enrichment Panel for Clinical Research October 13, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Appoints Steffen Hellmold as Senior Vice President, Business Development, Data Storage October 12, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience and CENTOGENE to Develop Advanced Sequencing Tools to Make Genetic Testing Rapidly Accessible for More Patients With Rare Diseases October 06, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Expands Expert Custom Alliance Panel Offering October 05, 2021 From Twist Bioscience Corporation Via Business Wire Illumina Ventures Closes $325 Million Fund Supporting Start-ups in Healthcare Innovation September 29, 2021 SOURCE: Illumina Via 3BL Media Twist Bioscience Appoints Dennis Cho as Senior Vice President, General Counsel and Chief Ethics and Compliance Officer September 27, 2021 From Twist Bioscience Via Business Wire Twist Bioscience Internally-Discovered Single Domain Antibody TB202-3 Shows Potent Binding to Multiple Strains of SARS-CoV-2, Including Alpha, Beta, and Gamma Strains, in Preclinical Studies September 23, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Collaborates with Deep Learning Experts deepCDR on Antibody Library Design September 23, 2021 From Twist Bioscience Corporation Via Business Wire Twist Bioscience Continues Commitment to Deliver Synthetic RNA Controls, now to Fight Delta Plus Variants of COVID-19 September 14, 2021 From Twist Bioscience Corporation Via Business Wire < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.